Petmed Express (PETS) Stock Statistics & Valuation Metrics

Petmed Express has a market cap or net worth of $73.12M. The enterprise value is $50.47M.

Petmed Express has 20,656,458 shares outstanding. The number of shares has decreased by -2.65% in one year.

Petmed Express’s return on equity (ROE) is -0.08 and return on invested capital (ROIC) is -9.89%.

The current PE Ratio of Petmed Express is -12.79. Petmed Express’s PEG ratio is <0.01.

In the last 12 months, Petmed Express had revenue of 281.06M and earned -7.46M in profits. Earnings per share was -0.37.

In the last 12 months, operating cash flow was 4.83M and capital expenditures -3.98M, giving a free cash flow of 856.00K billion.

Petmed Express pays an annual dividend of $0.3, resulting in a dividend yield of ―

Petmed Express upcoming earnings date is May 12, 2025, TBA Not Confirmed.

Petmed Express as a current ratio of 1.30, with Debt / Equity ratio of 1.15%

In the past 12 months, Petmed Express has paid 1.19M in taxes.

Petmed Express EV to EBITDA ratio is -37.62, with an EV/FCF ratio of -214.49.

Petmed Express has $50.10M in cash and marketable securities with ― in debt, giving a net cash position of -$49.00M billion.

Gross margin is 26.21%, with operating margin of -2.90%, and net profit margin of -2.66%.

The average price target for Petmed Express is $3.60, which is 11.43% higher than the current price. The consensus rating is Moderate Sell